{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:47:47Z","timestamp":1791899267386,"version":"4.3.4"},"reference-count":197,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation for Research and Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome\/polyendocrine metabolic ovarian syndrome (PCOS\/PMOS) is a common endocrine disorder with significant metabolic and reproductive implications. Increasing attention has focused on its potential long-term neurological consequences, including possible links to cognitive impairment and Alzheimer disease (AD), through overlapping biological pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a comprehensive PubMed search, from inception through October 2025, identifying studies on cognitive performance, brain structure and function, neurodegenerative biomarkers, and dementia risk in PCOS\/PMOS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Evidence supports multiple potential mechanistic pathways that could connect PCOS\/PMOS to AD-relevant biology, such as insulin resistance (IR), chronic inflammation, hormonal dysregulation, and cardiovascular dysfunction. These pathways converge on neurodegeneration processes such as impaired A\u03b2 clearance, tau hyperphosphorylation, oxidative stress, and cerebral metabolic deficits. Clinically, PCOS\/PMOS patients exhibit mild but reproducible impairments in executive function and memory, alongside structural and functional brain alterations, including hippocampal and white matter changes, and altered network connectivity. However, these findings are influenced by coexisting metabolic dysfunction, and direct epidemiological evidence linking PCOS\/PMOS to increased dementia incidence remains limited and inconsistent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence indicates that any association between PCOS\/PMOS and AD risk is likely mediated by metabolic comorbidities, particularly IR and obesity, rather than an independent effect of PCOS\/PMOS itself. However, clinical evidence for increased PCOS\/PMOS risk for cognitive vulnerability and dementia remain inconsistent and cognitive benefits from PCOS\/PMOS-specific interventions are lacking. Clinical focus should therefore remain on optimizing metabolic health, while longitudinal and interventional studies are required to clarify long-term neurological relationships and outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag206","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:16:02Z","timestamp":1788520562000},"source":"Crossref","is-referenced-by-count":0,"title":["Potential links between PCOS\/PMOS and Alzheimer disease and related dementias"],"prefix":"10.1210","volume":"10","author":[{"given":"Mina","family":"Amiri","sequence":"first","affiliation":[{"name":"Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences (TUMS) , Tehran 1411713119 ,","place":["Iran"]},{"name":"Foundation for Research and Education Excellence , Vestavia, AL 35243 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita","family":"Kakavand Hamidi","sequence":"additional","affiliation":[{"name":"Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences (TUMS) , Tehran 1411713119 ,","place":["Iran"]},{"name":"Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences (TUMS) , Tehran 1411713119 ,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L","family":"Farkas","sequence":"additional","affiliation":[{"name":"Foundation for Research and Education Excellence , Vestavia, AL 35243 ,","place":["USA"]},{"name":"Department of Biomedical Engineering, University of Southern California , Los Angeles, CA 90089 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-0692","authenticated-orcid":false,"given":"Richard P","family":"Buyalos","sequence":"additional","affiliation":[{"name":"Foundation for Research and Education Excellence , Vestavia, AL 35243 ,","place":["USA"]},{"name":"Department of Obstetrics and Gynecology, Heersink School of Medicine, University of Alabama at Birmingham (UAB) , Birmingham, AL 35249 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-0483","authenticated-orcid":false,"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Foundation for Research and Education Excellence , Vestavia, AL 35243 ,","place":["USA"]},{"name":"Department of Medicine, Heersink School of Medicine, UAB , Birmingham, AL 35249 ,","place":["USA"]},{"name":"Department of Healthcare Organization and Policy, School of Public Health, UAB , Birmingham, AL 35249 ,","place":["USA"]},{"name":"Department of Health Policy, Management, and Behavior, School of Public Health, University at Albany, SUNY , Rensselaer, NY 12144 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"10545","key":"2026101309015446500_bvag206-B1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"issue":"7","key":"2026101309015446500_bvag206-B2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1210\/clinem\/dgae917","article-title":"The influence of study quality, age, and geographic factors on PCOS prevalence-a systematic review and meta-analysis","volume":"110","author":"Amiri","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026101309015446500_bvag206-B3","doi-asserted-by":"crossref","first-page":"e1759","DOI":"10.1210\/clinem\/dgaf037","article-title":"Population-based vs health system and insurer records: significant underdiagnosis of PCOS","volume":"110","author":"Hatoum","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026101309015446500_bvag206-B4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynaecol"},{"issue":"2","key":"2026101309015446500_bvag206-B5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/diaspect.28.2.116","article-title":"The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment","volume":"28","author":"Dennett","year":"2015","journal-title":"Diabetes Spectr"},{"issue":"6","key":"2026101309015446500_bvag206-B6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2026101309015446500_bvag206-B7","first-page":"4085","volume-title":"Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling","author":"Azziz","year":"2002"},{"issue":"10","key":"2026101309015446500_bvag206-B8","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/clinem\/dgae488","article-title":"The association between obesity and polycystic ovary syndrome: an epidemiologic study of observational data","volume":"109","author":"Amiri","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026101309015446500_bvag206-B9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.fertnstert.2021.04.033","article-title":"Adiposity in polycystic ovary syndrome: excess versus dysfunction","volume":"116","author":"Azziz","year":"2021","journal-title":"Fertil Steril"},{"issue":"3","key":"2026101309015446500_bvag206-B10","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1210\/clinem\/dgab757","article-title":"Causes and consequences of polycystic ovary syndrome: insights from Mendelian randomization","volume":"107","author":"Zhu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026101309015446500_bvag206-B11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db20-0800","article-title":"Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke","volume":"70","author":"Zhu","year":"2021","journal-title":"Diabetes"},{"issue":"3","key":"2026101309015446500_bvag206-B12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham Gnanadass","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"Suppl 1","key":"2026101309015446500_bvag206-B13","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.fertnstert.2006.04.010","article-title":"Type 2 diabetes and polycystic ovary syndrome","volume":"86","author":"Legro","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"2026101309015446500_bvag206-B14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.fertnstert.2021.04.018","article-title":"Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome","volume":"116","author":"Persson","year":"2021","journal-title":"Fertil Steril"},{"issue":"1","key":"2026101309015446500_bvag206-B15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Amiri","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"2026101309015446500_bvag206-B16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgab134","article-title":"Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome","volume":"106","author":"Joham","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101309015446500_bvag206-B17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.822079","article-title":"Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"9","author":"Zhuang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2026101309015446500_bvag206-B18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","article-title":"Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"36","author":"Ramezani Tehrani","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2026101309015446500_bvag206-B19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"62","author":"Brutocao","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"2026101309015446500_bvag206-B20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/ijms25021158","article-title":"A cross-sectional study of Alzheimer-related proteins in women with polycystic ovary syndrome","volume":"25","author":"Butler","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2Part B","key":"2026101309015446500_bvag206-B21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cjco.2023.12.010","article-title":"Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian population cohort","volume":"6","author":"Vine","year":"2024","journal-title":"CJC Open"},{"issue":"1","key":"2026101309015446500_bvag206-B22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"2026101309015446500_bvag206-B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","article-title":"Clinical aspects of Alzheimer's disease","volume":"72","author":"Zv\u011b\u0159ov\u00e1","year":"2019","journal-title":"Clin Biochem"},{"key":"2026101309015446500_bvag206-B24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","article-title":"Genetics of Alzheimer's disease","volume":"87","author":"Chouraki","year":"2014","journal-title":"Adv Genet"},{"issue":"10","key":"2026101309015446500_bvag206-B25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3390\/ijms17101737","article-title":"Zinc finger and X-linked factor (ZFX) binds to human SET transcript 2 promoter and transactivates SET expression","volume":"17","author":"Xu","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"10)","key":"2026101309015446500_bvag206-B26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s44220-025-00502-7","article-title":"Diversity-sensitive brain clocks linked to biophysical mechanisms in aging and dementia","volume":"3","author":"Coronel-Oliveros","year":"2025","journal-title":"Nat Ment Health"},{"issue":"2","key":"2026101309015446500_bvag206-B27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ncl.2023.01.001","article-title":"Sex differences in Alzheimer's disease","volume":"41","author":"Aggarwal","year":"2023","journal-title":"Neurol Clin"},{"issue":"8","key":"2026101309015446500_bvag206-B28","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1002\/alz.13844","article-title":"Sex and gender differences in cognitive resilience to aging and Alzheimer's disease","volume":"20","author":"Arenaza-Urquijo","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2026101309015446500_bvag206-B29","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1111\/ejn.14758","article-title":"Obesity and Alzheimer's disease: molecular bases","volume":"52","author":"Picone","year":"2020","journal-title":"Eur J Neurosci"},{"issue":"10","key":"2026101309015446500_bvag206-B30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"18","key":"2026101309015446500_bvag206-B31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038086","article-title":"Neuroinflammation in dementia: a meta-analysis of PET imaging studies","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2026101309015446500_bvag206-B32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.yhbeh.2007.02.007","article-title":"Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women","volume":"51","author":"Schattmann","year":"2007","journal-title":"Horm Behav"},{"key":"2026101309015446500_bvag206-B33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2024.101160","article-title":"Progestagens and progesterone receptor modulation: effects on the brain, mood, stress, and cognition in females","volume":"76","author":"Bencker","year":"2025","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"2026101309015446500_bvag206-B34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41574-024-01061-0","article-title":"Leveraging research into sex differences and steroid hormones to improve brain health","volume":"21","author":"Lee","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2026101309015446500_bvag206-B35","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf052","article-title":"Influence of dehydroepiandrosterone sulphate levels on the slower age-related decline in grey matter in younger women with polycystic ovary syndrome","volume":"7","author":"Chen","year":"2025","journal-title":"Brain Commun"},{"issue":"17","key":"2026101309015446500_bvag206-B36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","article-title":"Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease","volume":"76","author":"Li","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"2026101309015446500_bvag206-B37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2010-1222","article-title":"Role of oxidative stress in the progression of Alzheimer's disease","volume":"19","author":"Sultana","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2026101309015446500_bvag206-B38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.freeradbiomed.2006.11.006","article-title":"Involvement of PI3K\/PKG\/ERK1\/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"42","author":"Abdul","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2026101309015446500_bvag206-B39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13030-024-00320-w","article-title":"The impact of polycystic ovary syndrome on attention: an empirical investigation","volume":"19","author":"Redkar","year":"2025","journal-title":"Biopsychosoc Med"},{"issue":"10","key":"2026101309015446500_bvag206-B40","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1210\/js.2019-00112","article-title":"Dysglycemia, not altered sex steroid hormones, affects cognitive function in polycystic ovary syndrome","volume":"3","author":"Jarrett","year":"2019","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026101309015446500_bvag206-B41","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.fertnstert.2016.01.034","article-title":"Does polycystic ovary syndrome affect cognition? A functional magnetic resonance imaging study exploring working memory","volume":"105","author":"Soleman","year":"2016","journal-title":"Fertil Steril"},{"issue":"1","key":"2026101309015446500_bvag206-B42","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jc.2015-2318","article-title":"White matter microstructure and cognitive function in young women with polycystic ovary syndrome","volume":"101","author":"Rees","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026101309015446500_bvag206-B43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144116","article-title":"Regional brain glucose hypometabolism in young women with polycystic ovary syndrome: possible link to mild insulin resistance","volume":"10","author":"Castellano","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2026101309015446500_bvag206-B44","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.fertnstert.2015.07.397","article-title":"Cognitive function in women with polycystic ovary syndrome (PCOS): impact of reproductive and metabolic factors","volume":"104","author":"Lujan","year":"2015","journal-title":"Fertil Steril"},{"issue":"8-10","key":"2026101309015446500_bvag206-B45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.psyneuen.2007.06.010","article-title":"Cognitive functioning in polycystic ovary syndrome","volume":"32","author":"Barnard","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"2026101309015446500_bvag206-B46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.603279","article-title":"Changes in resting-state cerebral activity in women with polycystic ovary syndrome: a functional MR imaging study","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026101309015446500_bvag206-B47","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1210\/clinem\/dgaa843","article-title":"Polycystic ovary syndrome and brain: an update on structural and functional studies","volume":"106","author":"Ozgen Saydam","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026101309015446500_bvag206-B48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-2011-110341","article-title":"Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial","volume":"26","author":"Wharton","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2026101309015446500_bvag206-B49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166596","article-title":"Regulation of retinoid mediated StAR transcription and steroidogenesis in hippocampal neuronal cells: implications for StAR in protecting Alzheimer's disease","volume":"1869","author":"Manna","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"2026101309015446500_bvag206-B50","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol Rev"},{"issue":"6","key":"2026101309015446500_bvag206-B51","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00737-025-01628-4","article-title":"Oral contraceptive treatment improves cognitive performance in polycystic ovarian syndrome (PCOS) patients","volume":"28","author":"Kumari","year":"2025","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"2026101309015446500_bvag206-B52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.fertnstert.2013.02.054","article-title":"Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study","volume":"100","author":"Marsh","year":"2013","journal-title":"Fertil Steril"},{"issue":"16","key":"2026101309015446500_bvag206-B53","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1021\/acschemneuro.4c00352","article-title":"Pterostilbene ameliorates cognitive impairment in polycystic ovary syndrome rat model through improving insulin resistance via the IRS-1\/PI3K\/Akt\/GSK-3\u03b2 pathway: a comparative study with metformin","volume":"15","author":"Foda","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"2026101309015446500_bvag206-B54","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"issue":"7","key":"2026101309015446500_bvag206-B55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/09513590.2017.1295440","article-title":"Structural imaging of the brain reveals decreased total brain and total gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts","volume":"33","author":"Ozgen Saydam","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2026101309015446500_bvag206-B56","doi-asserted-by":"crossref","DOI":"10.4172\/2471-9455.1000133","article-title":"Hearing and auditory working memory in women with polycystic ovarian syndrome (PCOS)","volume":"3","author":"Sundararaj","year":"2017","journal-title":"J Phonet Audiol"},{"issue":"5","key":"2026101309015446500_bvag206-B57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.yhbeh.2007.02.002","article-title":"Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study","volume":"51","author":"Schattmann","year":"2007","journal-title":"Horm Behav"},{"key":"2026101309015446500_bvag206-B58","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104535","article-title":"Plasma luteinizing hormone level affects the brain activity of patients with polycystic ovary syndrome","volume":"112","author":"Lai","year":"2020","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"2026101309015446500_bvag206-B59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"2026101309015446500_bvag206-B60","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/ijms25042409","article-title":"A cross-sectional study of protein changes associated with dementia in non-obese weight matched women with and without polycystic ovary syndrome","volume":"25","author":"Butler","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2026101309015446500_bvag206-B61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/09727531221115318","article-title":"EEG-ERP correlates of cognitive dysfunction in polycystic ovarian syndrome","volume":"29","author":"Showkath","year":"2022","journal-title":"Ann Neurosci"},{"issue":"4","key":"2026101309015446500_bvag206-B62","first-page":"372","article-title":"Endophenotypic correlates of cognitive function in reproductive-age individuals with polycystic ovary syndrome","volume":"3","author":"Huddleston","year":"2022","journal-title":"F S Rep"},{"issue":"4","key":"2026101309015446500_bvag206-B63","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026101309015446500_bvag206-B64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008898","article-title":"Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation","volume":"5","author":"Nunez-Iglesias","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"2026101309015446500_bvag206-B65","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1210\/clinem\/dgae481","article-title":"Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome","volume":"110","author":"Henney","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026101309015446500_bvag206-B66","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101309015446500_bvag206-B67","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101309015446500_bvag206-B68","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","article-title":"Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity","volume":"88","author":"Baillargeon","year":"2007","journal-title":"Fertil Steril"},{"issue":"1","key":"2026101309015446500_bvag206-B69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/endrev\/bnad023","article-title":"The emerging therapeutic potential of kisspeptin and neurokinin B","volume":"45","author":"Patel","year":"2024","journal-title":"Endocr Rev"},{"issue":"1","key":"2026101309015446500_bvag206-B70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026101309015446500_bvag206-B71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"2026101309015446500_bvag206-B72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"21","key":"2026101309015446500_bvag206-B73","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026101309015446500_bvag206-B74","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13407","article-title":"Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: a meta-analysis","volume":"86","author":"Wu","year":"2021","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"2026101309015446500_bvag206-B75","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cen.12803","article-title":"Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance","volume":"83","author":"Lambert","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2026101309015446500_bvag206-B76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2026101309015446500_bvag206-B77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/NSS.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies","volume":"10","author":"Fernandez","year":"2018","journal-title":"Nat Sci Sleep"},{"issue":"12","key":"2026101309015446500_bvag206-B78","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"2026101309015446500_bvag206-B79","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/jc.2017-02667","article-title":"Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes","volume":"103","author":"Berni","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026101309015446500_bvag206-B80","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/mp.2015.183","article-title":"Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: a population-based nationwide study in Sweden","volume":"21","author":"Kosidou","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"9","key":"2026101309015446500_bvag206-B81","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biopsych.2016.09.022","article-title":"Maternal polycystic ovary syndrome and risk for attention-deficit\/hyperactivity disorder in the offspring","volume":"82","author":"Kosidou","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2026101309015446500_bvag206-B82","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0033291719000424","article-title":"Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?","volume":"50","author":"Cesta","year":"2020","journal-title":"Psychol Med"},{"issue":"9","key":"2026101309015446500_bvag206-B83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"3","key":"2026101309015446500_bvag206-B84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"issue":"4","key":"2026101309015446500_bvag206-B85","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208104","article-title":"Associations of polycystic ovary syndrome with indicators of brain health at midlife in the CARDIA cohort","volume":"102","author":"Huddleston","year":"2024","journal-title":"Neurology"},{"issue":"10","key":"2026101309015446500_bvag206-B86","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/molecules22101692","article-title":"\u03b2-Amyloid and the pathomechanisms of Alzheimer's disease: a comprehensive view","volume":"22","author":"Penke","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"2026101309015446500_bvag206-B87","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"2026101309015446500_bvag206-B88","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jnnp.73.5.508","article-title":"Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study","volume":"73","author":"Garrido","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"21","key":"2026101309015446500_bvag206-B89","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.3390\/molecules26216651","article-title":"Biomedical applications of translational optical imaging: from molecules to humans","volume":"26","author":"Farkas","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"2026101309015446500_bvag206-B90","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","article-title":"Gender and incidence of dementia in the Framingham Heart Study from mid-adult life","volume":"11","author":"Ch\u00eane","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2026101309015446500_bvag206-B91","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1007\/s11357-024-01151-x","article-title":"Sex differences in interacting genetic and functional connectivity biomarkers in Alzheimer's disease","volume":"46","author":"Williamson","year":"2024","journal-title":"Geroscience"},{"issue":"3","key":"2026101309015446500_bvag206-B92","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10339-025-01265-w","article-title":"Cognitive strategy in verbal fluency: sex differences, menstrual cycle, and menopause effects","volume":"26","author":"Cowell","year":"2025","journal-title":"Cogn Process"},{"issue":"5","key":"2026101309015446500_bvag206-B93","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70206","article-title":"Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes","volume":"21","author":"Mei","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2026101309015446500_bvag206-B94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s44321-024-00190-3","article-title":"Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease","volume":"17","author":"Biel","year":"2025","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2026101309015446500_bvag206-B95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13195-024-01610-9","article-title":"Associations between sex and lifestyle activities with cognitive reserve in mid-life adults with genetic risk for Alzheimer's disease","volume":"16","author":"Qi","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"2026101309015446500_bvag206-B96","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41380-024-02798-w","article-title":"Prenatal immune origins of brain aging differ by sex","volume":"30","author":"Goldstein","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"5","key":"2026101309015446500_bvag206-B97","first-page":"256","article-title":"Serum amyloid P component level in Alzheimer's disease","volume":"7","author":"Nishiyama","year":"1996","journal-title":"Dementia"},{"issue":"6","key":"2026101309015446500_bvag206-B98","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1159\/000178756","article-title":"Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease","volume":"26","author":"Verwey","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2026101309015446500_bvag206-B99","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/NDT.S385014","article-title":"Changes in mood, anxiety, and cognition with polycystic ovary syndrome treatment: a longitudinal, naturalistic study","volume":"18","author":"Sukhapure","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"2026101309015446500_bvag206-B100","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1096\/fj.201802653RR","article-title":"Dysregulation of hypothalamic-pituitary estrogen receptor \u03b1-mediated signaling causes episodic LH secretion and cystic ovary","volume":"33","author":"Arao","year":"2019","journal-title":"FASEB J"},{"issue":"1","key":"2026101309015446500_bvag206-B101","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026101309015446500_bvag206-B102","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/j.2040-4603.2022.tb00215.x","article-title":"Polycystic ovary syndrome and the neuroendocrine consequences of androgen excess","volume":"12","author":"Silva","year":"2022","journal-title":"Compr Physiol"},{"issue":"1","key":"2026101309015446500_bvag206-B103","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-015-0715-6","article-title":"Role of the steroidogenic acute regulatory protein in health and disease","volume":"51","author":"Manna","year":"2016","journal-title":"Endocrine"},{"issue":"6","key":"2026101309015446500_bvag206-B104","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166738","article-title":"Protective function of StAR in amyloid-\u03b2 accumulated hippocampal neurotoxicity and neurosteroidogenesis: mechanistic insights into Alzheimer's disease","volume":"1869","author":"Manna","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"2026101309015446500_bvag206-B105","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70025","article-title":"A recent update on the role of estrogen and progesterone in Alzheimer's disease","volume":"42","author":"Suganya","year":"2024","journal-title":"Cell Biochem Funct"},{"key":"2026101309015446500_bvag206-B106","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fendo.2019.00298","article-title":"Kisspeptin and polycystic ovary syndrome","volume":"10","author":"Tang","year":"2019","journal-title":"Front Endocrinol"},{"issue":"8","key":"2026101309015446500_bvag206-B107","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/biom14080918","article-title":"Are women with polycystic ovary syndrome at increased risk of Alzheimer disease? Lessons from insulin resistance, tryptophan and gonadotropin disturbances and their link with amyloid-beta aggregation","volume":"14","author":"Sobczuk","year":"2024","journal-title":"Biomolecules"},{"issue":"11","key":"2026101309015446500_bvag206-B108","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/09513590.2019.1613359","article-title":"The impact of sex hormones and metabolic markers on depressive symptoms and cognitive functioning in PCOS patients","volume":"35","author":"Franik","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2026101309015446500_bvag206-B109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114665","article-title":"Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome","volume":"647","author":"Yang","year":"2022","journal-title":"Anal Biochem"},{"key":"2026101309015446500_bvag206-B110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113808","article-title":"Estrogen as a key regulator of energy homeostasis and metabolic health","volume":"156","author":"Mahboobifard","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"2026101309015446500_bvag206-B111","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70541","article-title":"Age of menopause and dementia risk in 10,832 women from the Swedish Twin Registry","volume":"21","author":"Saelzler","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2026101309015446500_bvag206-B112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-2008-14208","article-title":"Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men","volume":"14","author":"Verdile","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"2026101309015446500_bvag206-B113","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2017.06.005","article-title":"Sex-specific association of sex hormones and gonadotropins, with brain amyloid and hippocampal neurodegeneration","volume":"58","author":"Lee","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2026101309015446500_bvag206-B114","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yhbeh.2008.02.006","article-title":"Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats","volume":"54","author":"Berry","year":"2008","journal-title":"Horm Behav"},{"key":"2026101309015446500_bvag206-B115","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2019.104590","article-title":"Reducing luteinizing hormone levels after ovariectomy improves spatial memory: possible role of brain-derived neurotrophic factor","volume":"118","author":"Bohm-Levine","year":"2020","journal-title":"Horm Behav"},{"issue":"5","key":"2026101309015446500_bvag206-B116","first-page":"e426","article-title":"Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies","volume":"12","author":"Cherbuin","year":"2011","journal-title":"Obes Rev"},{"issue":"1","key":"2026101309015446500_bvag206-B117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030378","article-title":"Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity","volume":"7","author":"Puig","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"2026101309015446500_bvag206-B118","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/en.2009-1196","article-title":"Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model","volume":"151","author":"Kohjima","year":"2010","journal-title":"Endocrinology"},{"issue":"8","key":"2026101309015446500_bvag206-B119","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2007.06.004","article-title":"Amyloid beta as a regulator of lipid homeostasis","volume":"13","author":"Grimm","year":"2007","journal-title":"Trends Mol Med"},{"issue":"6","key":"2026101309015446500_bvag206-B120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J Diabetes Investig"},{"issue":"12","key":"2026101309015446500_bvag206-B121","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/db06-0485","article-title":"Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency","volume":"55","author":"Clodfelder-Miller","year":"2006","journal-title":"Diabetes"},{"issue":"11","key":"2026101309015446500_bvag206-B122","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00018-005-5597-y","article-title":"Glycogen synthase kinase 3\u03b2 and Alzheimer's disease: pathophysiological and therapeutic significance","volume":"63","author":"Balaraman","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2026101309015446500_bvag206-B123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease","volume":"7","author":"de la Monte","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"6938","key":"2026101309015446500_bvag206-B124","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3\u03b1 regulates production of Alzheimer's disease amyloid-\u03b2 peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"issue":"8","key":"2026101309015446500_bvag206-B125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","article-title":"Potential roles of insulin and IGF-1 in Alzheimer's disease","volume":"26","author":"Gasparini","year":"2003","journal-title":"Trends Neurosci"},{"issue":"53","key":"2026101309015446500_bvag206-B126","doi-asserted-by":"crossref","first-page":"56004","DOI":"10.1074\/jbc.M407283200","article-title":"Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy","volume":"279","author":"Morelli","year":"2004","journal-title":"J Biol Chem"},{"issue":"11","key":"2026101309015446500_bvag206-B127","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","article-title":"Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease","volume":"97","author":"Small","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2026101309015446500_bvag206-B128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am J Pathol"},{"issue":"10","key":"2026101309015446500_bvag206-B129","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2004.02.006","article-title":"N\u025b-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease","volume":"36","author":"Giron\u00e8s","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"2026101309015446500_bvag206-B130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106773","article-title":"FSH, LH, lipid and adipokines in polycystic ovary syndrome: clinical biochemistry insights for diagnosis and management","volume":"251","author":"Merza","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2026101309015446500_bvag206-B131","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"2026101309015446500_bvag206-B132","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-161149","article-title":"Recent progress in Alzheimer's disease research, part 2: genetics and epidemiology","volume":"57","author":"Robinson","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2026101309015446500_bvag206-B133","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"2026101309015446500_bvag206-B134","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"issue":"5","key":"2026101309015446500_bvag206-B135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"2026101309015446500_bvag206-B136","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.3390\/ijms13067303","article-title":"The toxicity of amyloid \u03b2 oligomers","volume":"13","author":"Zhao","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"13","key":"2026101309015446500_bvag206-B137","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2174\/1567205015666180911151716","article-title":"The role of lipids and membranes in the pathogenesis of Alzheimer's disease: a comprehensive view","volume":"15","author":"Penke","year":"2018","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"2026101309015446500_bvag206-B138","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70610","article-title":"Cardiovascular contributions to dementia: examining sex differences and female-specific factors","volume":"21","author":"Wood Alexander","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2026101309015446500_bvag206-B139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-200245","article-title":"Does gender influence the relationship between high blood pressure and dementia? Highlighting areas for further investigation","volume":"78","author":"Blanken","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2026101309015446500_bvag206-B140","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1152\/jn.00841.2017","article-title":"Fifty years of microneurography: learning the language of the peripheral sympathetic nervous system in humans","volume":"119","author":"Shoemaker","year":"2018","journal-title":"J Neurophysiol"},{"issue":"27","key":"2026101309015446500_bvag206-B141","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","article-title":"Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease","volume":"28","author":"Boland","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"2026101309015446500_bvag206-B142","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5603\/CJ.a2017.0032","article-title":"Echocardiographic evaluation of diastolic functions in patients with polycystic ovary syndrome: a comperative study of diastolic functions in sub-phenotypes of polycystic ovary syndrome","volume":"24","author":"Yildirim","year":"2017","journal-title":"Cardiol J"},{"issue":"11","key":"2026101309015446500_bvag206-B143","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026101309015446500_bvag206-B144","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/09513590.2016.1149812","article-title":"Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome","volume":"32","author":"Guoqing","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2026101309015446500_bvag206-B145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2025.103316","article-title":"Associations between cardiac autonomic function and cognition across the adult female lifespan","volume":"260","author":"Duval","year":"2025","journal-title":"Auton Neurosci"},{"issue":"6156","key":"2026101309015446500_bvag206-B146","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"issue":"6012","key":"2026101309015446500_bvag206-B147","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"2026101309015446500_bvag206-B148","article-title":"Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2026101309015446500_bvag206-B149","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11010-023-04867-0","article-title":"Discrete interplay of gut microbiota L-tryptophan metabolites in host biology and disease","volume":"479","author":"Ranhotra","year":"2024","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2026101309015446500_bvag206-B150","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101309015446500_bvag206-B151","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13417","article-title":"Characterization of gut microbiota in polycystic ovary syndrome: findings from a lean population","volume":"51","author":"Mammadova","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"7122","key":"2026101309015446500_bvag206-B152","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"7","key":"2026101309015446500_bvag206-B153","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2017-02799","article-title":"Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity","volume":"103","author":"Insenser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026101309015446500_bvag206-B154","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"2026101309015446500_bvag206-B155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41522-021-00231-6","article-title":"Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients","volume":"7","author":"Chen","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2026101309015446500_bvag206-B156","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front Microbiol"},{"issue":"5 Pt 2","key":"2026101309015446500_bvag206-B157","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.fertnstert.2025.09.025","article-title":"Polycystic ovary syndrome in 2025-insights and innovations","volume":"124","author":"Dokras","year":"2025","journal-title":"Fertil Steril"},{"issue":"6","key":"2026101309015446500_bvag206-B158","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2026101309015446500_bvag206-B159","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat Med"},{"issue":"5","key":"2026101309015446500_bvag206-B160","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2026101309015446500_bvag206-B161","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"2026101309015446500_bvag206-B162","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"2026101309015446500_bvag206-B163","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat Commun"},{"key":"2026101309015446500_bvag206-B164","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.675581","article-title":"Mitochondrial DNA 4977 bp deletion in peripheral blood is associated with polycystic ovary syndrome","volume":"12","author":"Ye","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2026101309015446500_bvag206-B165","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/09513590.2018.1459548","article-title":"Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients","volume":"34","author":"Lin","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2026101309015446500_bvag206-B166","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2018.10.021","article-title":"Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice","volume":"157","author":"Li","year":"2019","journal-title":"Biochimie"},{"key":"2026101309015446500_bvag206-B167","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2016.11.010","article-title":"Pathologic significance of SET\/I2PP2A-mediated PP2A and non-PP2A pathways in polycystic ovary syndrome (PCOS)","volume":"464","author":"Jiang","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2026101309015446500_bvag206-B168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/jme.0.0330059","article-title":"The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray","volume":"33","author":"Diao","year":"2004","journal-title":"J Mol Endocrinol"},{"issue":"24","key":"2026101309015446500_bvag206-B169","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M112.446070","article-title":"Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease","volume":"288","author":"Basurto-Islas","year":"2013","journal-title":"J Biol Chem"},{"issue":"40","key":"2026101309015446500_bvag206-B170","doi-asserted-by":"crossref","first-page":"27677","DOI":"10.1074\/jbc.M114.565358","article-title":"Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau","volume":"289","author":"Arif","year":"2014","journal-title":"J Biol Chem"},{"key":"2026101309015446500_bvag206-B171","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2020.10.009","article-title":"Novel role of CXCL14 in modulating STAR expression in luteinized granulosa cells: implication for progesterone synthesis in PCOS patients","volume":"230","author":"Qi","year":"2021","journal-title":"Transl Res"},{"issue":"1","key":"2026101309015446500_bvag206-B172","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12978-021-01203-x","article-title":"Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review","volume":"18","author":"Sarahian","year":"2021","journal-title":"Reprod Health"},{"issue":"2","key":"2026101309015446500_bvag206-B173","doi-asserted-by":"crossref","DOI":"10.5812\/ijem-159124","article-title":"Uncovering the hidden connections between PCOS and Alzheimer's disease: a two-sample Mendelian randomization perspective","volume":"23","author":"Motafeghi","year":"2025","journal-title":"Int J Endocrinol Metab"},{"issue":"8","key":"2026101309015446500_bvag206-B174","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3390\/ijms22083923","article-title":"Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome","volume":"22","author":"Dabravolski","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026101309015446500_bvag206-B175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2010-1239","article-title":"Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment","volume":"19","author":"Smith","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2026101309015446500_bvag206-B176","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","article-title":"Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation","volume":"17","author":"Mark","year":"1997","journal-title":"J Neurosci"},{"issue":"5","key":"2026101309015446500_bvag206-B177","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","article-title":"Metal dyshomeostasis and oxidative stress in Alzheimer's disease","volume":"62","author":"Greenough","year":"2013","journal-title":"Neurochem Int"},{"issue":"1-2","key":"2026101309015446500_bvag206-B178","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J Neurol Sci"},{"issue":"5","key":"2026101309015446500_bvag206-B179","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin Biochem"},{"issue":"6","key":"2026101309015446500_bvag206-B180","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4717-10.2011","article-title":"Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease","volume":"31","author":"Yao","year":"2011","journal-title":"J Neurosci"},{"issue":"2","key":"2026101309015446500_bvag206-B181","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"2026101309015446500_bvag206-B182","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","article-title":"Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease","volume":"120","author":"Sheng","year":"2012","journal-title":"J Neurochem"},{"key":"2026101309015446500_bvag206-B183","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2015.05.013","article-title":"Metabolism alteration in follicular niche: the nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome","volume":"86","author":"Zhao","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2026101309015446500_bvag206-B184","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/ijpvm.IJPVM_576_17","article-title":"Oxidative stress and polycystic ovary syndrome: a brief review","volume":"10","author":"Mohammadi","year":"2019","journal-title":"Int J Prev Med"},{"issue":"1","key":"2026101309015446500_bvag206-B185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-019-0509-4","article-title":"Polycystic ovary syndrome and mitochondrial dysfunction","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"issue":"32","key":"2026101309015446500_bvag206-B186","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.1009485107","article-title":"Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease","volume":"107","author":"Lipinski","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101309015446500_bvag206-B187","doi-asserted-by":"crossref","DOI":"10.1177\/11786469221099214","article-title":"The kynurenine pathway and polycystic ovary syndrome: inflammation as a common denominator","volume":"15","author":"Jovanovic","year":"2022","journal-title":"Int J Tryptophan Res"},{"issue":"4","key":"2026101309015446500_bvag206-B188","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"2026101309015446500_bvag206-B189","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/135100002125000550","article-title":"Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease","volume":"7","author":"Guillemin","year":"2002","journal-title":"Redox Rep"},{"issue":"7","key":"2026101309015446500_bvag206-B190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"2026101309015446500_bvag206-B191","article-title":"Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites","volume":"8","author":"Meier-Stephenson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"2026101309015446500_bvag206-B192","article-title":"Abnormal activation of tryptophan-kynurenine pathway in women with polycystic ovary syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"3","key":"2026101309015446500_bvag206-B193","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4993","article-title":"Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome","volume":"35","author":"Hou","year":"2021","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"2026101309015446500_bvag206-B194","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/ph16030351","article-title":"The kynurenine pathway in healthy subjects and subjects with obesity, depression and chronic obstructive pulmonary disease","volume":"16","author":"Farup","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"2026101309015446500_bvag206-B195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"issue":"2","key":"2026101309015446500_bvag206-B196","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-180297","article-title":"Metabolic syndrome and amyloid accumulation in the aging brain","volume":"65","author":"Gomez","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2026101309015446500_bvag206-B197","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-19-0259","article-title":"Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study","volume":"181","author":"Wium-Andersen","year":"2019","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/11\/bvag206\/71791346\/bvag206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/11\/bvag206\/71791346\/bvag206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:02:23Z","timestamp":1791896543000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag206\/8881691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":197,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag206","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,10,5]]},"article-number":"bvag206"}}